Bad news on multiple fronts hit stocks.
News & Analysis: Intra-Cellular Therapies
Investors disliked the biotech's bad news a lot more than they liked its good news.
ITCI earnings call for the period ending March 31, 2019.
ITCI earnings call for the period ending December 31, 2018.
Bummer regulatory news causes traders to flee from these two biopharmas. Here's what investors need to know.
Despite a rising market, these stocks fell. Find out why.
Shares jumped after the company announced some upbeat clinical news and received an analyst upgrade.
These stocks gained ground even as Wall Street struggled. Find out why.
Shares roar higher after the company provides investors with some good regulatory news.
On a mixed day for the market, these stocks fell. Find out why.